Oxyresveratrol Synthesis via Alkene Coupling and Selective Oxidation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for synthesizing resveratrol-type compounds, such as oxyresveratrol, are inefficient and require complex protection/deprotection chemistry and metal catalysis, resulting in low yields and potential safety concerns.

Innovation Solution

A method involving the reaction of a compound of Formula I-3 with an aldehyde A1 under conditions suitable for forming a compound of Formula I, using an inorganic base such as Na2CO3 and an organic solvent like n-methyl-2-pyrrolidone, to produce oxyresveratrol with high yields and improved bioactivity.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If conventional synthetic methods using metal catalysis and protection/deprotection chemistry are used, then resveratrol-type compounds can be synthesized, but the synthesis requires multiple steps, complex procedures, and results in low yields

Engineering Contradiction:
Improvesynthesis yieldVSAvoidsynthetic procedure complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The synthesis is divided into distinct functional stages: (1) formation of the central alkene bond via coupling reaction, (2) selective oxidation of the alkene to diol, and (3) dehydrogenation to form the final alkene product. Each stage uses specialized reagents and conditions optimized for that specific transformation, allowing complex molecular construction through manageable sequential steps.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent employs intermediate compounds with specific functional groups that facilitate the synthesis. The vinyl halide intermediate and the diol intermediate serve as crucial bridging structures that enable the transformation from simple starting materials to the final resveratrol-type compound through controlled chemical reactions.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Manufacturing precision

If protection/deprotection chemistry is used to protect phenolic hydroxyl groups, then the central alkene can be formed, but the number of synthetic steps increases and the process becomes more complex

Engineering Contradiction:
Improveselectivity of reactionVSAvoidnumber of synthetic steps
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The patent applies local quality by using selective oxidation conditions that target only the central alkene bond for oxidation to the diol intermediate, while leaving the phenolic hydroxyl groups untouched. This localized chemical transformation occurs at specific molecular sites without affecting other functional groups, eliminating the need for protective groups.

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

Instead of protecting the hydroxyl groups before alkene formation and then deprotecting afterward, the patent inverts the approach by forming the alkene first with unprotected hydroxyl groups, then selectively oxidizing the alkene, and finally dehydrogenating to complete the synthesis. This reverse sequence reduces steps by eliminating unnecessary protection/deprotection cycles.

Inventive Principle:
Principle #13The other way round (Inversion)

3Manufacturing precision

If multiple synthetic steps with protection/deprotection chemistry are used, then the central alkene can be formed, but the time and resources required for synthesis increase

Engineering Contradiction:
Improveformation of central alkeneVSAvoidsynthesis time
Core Design Contradiction:
Manufacturing precisionVSLoss of time

Solution Approach 1:

The patent implements continuous useful action by designing a synthesis pathway where each reaction step directly contributes to building the final molecule without interruption. The sequential transformations—coupling, oxidation, dehydrogenation—proceed in an uninterrupted sequence with each step's product serving as the next step's reactant, maximizing the continuity of productive chemical transformation.

Inventive Principle:
Principle #20Continuity of useful action

Solution Approach 2:

The patent applies preliminary action by pre-forming the central alkene bond in the first coupling step before any oxidation or dehydrogenation occurs. This preliminary establishment of the core molecular framework allows subsequent steps to focus solely on functional group transformations rather than simultaneous bond formation and functionalization.

Inventive Principle:
Principle #10Preliminary action

4Productivity

If metal catalysis is used for coupling chemistry, then the central alkene can be formed, but safety concerns arise from heavy metal catalysts

Engineering Contradiction:
Improvecoupling reaction efficiencyVSAvoidsafety concerns from metal catalysts
Core Design Contradiction:
ProductivityVSObject-affected harmful factors

Solution Approach 1:

The patent employs stoichiometric or sub-stoichiometric amounts of organometallic reagents (such as organozinc or organoboron compounds) that serve as single-use coupling partners. These reagents perform the alkene bond formation function and are then consumed in the reaction, eliminating the need for recoverable metal catalysts and reducing safety concerns associated with heavy metal handling and disposal.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method achieves high yields and higher biological activity of oxyresveratrol compared to commercially available biologically extracted oxyresveratrol, with advantages including high reaction efficiency, high purity, low costs, and the absence of heavy metal catalysts.

Implementation Method 1

contacting a compound of Formula I-3 with an aldehyde A1 under conditions suitable to form a compound of Formula I

Methodology Applied
Scientific EffectNucleophilic addition: Chemical Bonding

Implementation Method 2

contacting a compound of Formula I-3 with an aldehyde A1 under conditions suitable to form a compound of Formula I

Methodology Applied
Scientific EffectElimination reaction: Chemical Bonding

Implementation Method 3

Utilizing a suitable inorganic base (e.g., NaOC6H5, Na2SiO3, Ca(OH)2, Mg(OH)2, LiOH, Cs2CO3, K3PO4, t-buOK, K2CO3, and Na2CO3) in the contacting step

Methodology Applied
Scientific EffectDeprotonation: Chemical Bonding

Implementation Method 4

Performing the reaction at a temperature of about 70-100 degrees Celsius, such as about 85-95 degrees Celsius

Methodology Applied
Scientific EffectThermal heating: Heating

Data Source

PatentUS20250154089A1Methods for preparing oxyresveratrol and derivatives thereof
Publication Date: 2025.05.15 CALIWAY BIOPHARM
  • US20250154089A1 patent drawing
  • US20250154089A1 patent drawing
  • US20250154089A1 patent drawing

AI summary

The present disclosure is directed to novel processes for producing resveratrol-type compounds (e.g., oxyresveratrol), salts thereof, hydrates thereof, and physical compositions thereof sans protecting group chemistry.